{"title":"International Society of Refractive Keratoplasty. 1993 Mid-Summer Symposium July 23-25, 1993. Minneapolis, Minn.","authors":"S B Robin","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":77346,"journal":{"name":"Refractive & corneal surgery","volume":"9 6","pages":"481-7"},"PeriodicalIF":0.0,"publicationDate":"1993-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"19110172","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
N A Sher, J M Frantz, A Talley, P Parker, S S Lane, C Ostrov, E Carpel, D Doughman, J DeMarchi, R Lindstrom
{"title":"Topical diclofenac in the treatment of ocular pain after excimer photorefractive keratectomy.","authors":"N A Sher, J M Frantz, A Talley, P Parker, S S Lane, C Ostrov, E Carpel, D Doughman, J DeMarchi, R Lindstrom","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>Following excimer laser photorefractive keratectomy, patients experience significant ocular pain until corneal reepithelialization. Despite the use of cold compresses, bandage soft contact lenses, cycloplegics, narcotics, and topical corticosteroids, the pain has not been adequately controlled in many patients.</p><p><strong>Methods: </strong>A randomized, double-masked, parallel-group study of diclofenac sodium 0.1% ophthalmic solution and its placebo vehicle was evaluated. Patients undergoing excimer myopic photorefractive keratectomy on their second eye were admitted overnight. Postoperative procedures included two drops of diclofenac or placebo immediately after surgery and then qid until reepithelialization, topical tobramycin (qid), 0.1% fluorometholone (q2h), cycloplegics, and a disposable soft contact lens. Thirty-two patients (diclofenac = 16, placebo = 16) were evaluated from +30 minutes to +96 hours by several types of questionnaires.</p><p><strong>Results: </strong>Most patients who received placebo experienced pain, starting within 1 hour, peaking at 4 to 6 hours and lasting 36 to 48 hours. The diclofenac-treated patients rarely experienced the early peak in pain, had less pain overall until 72 hours postoperatively, and experienced significantly less photophobia and burning/stinging. Significantly fewer patients on diclofenac required oral narcotics. Three patients (diclofenac = 2, placebo = 1) developed corneal infiltrates, the etiology of which is not known. In a separate study we conducted, there was no difference in epithelial healing times between the diclofenac-treated eyes and those not receiving the drug.</p><p><strong>Conclusions: </strong>Diclofenac appears to significantly reduce the ocular pain following excimer photorefractive keratectomy.</p>","PeriodicalId":77346,"journal":{"name":"Refractive & corneal surgery","volume":"9 6","pages":"425-36"},"PeriodicalIF":0.0,"publicationDate":"1993-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"19110246","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"American Society for Cataract and Refractive Surgery. Summer symposium on refractive surgery. August 26-29, 1993 Los Angeles, Calif.","authors":"K. Wellish","doi":"10.3928/1081-597X-19931101-17","DOIUrl":"https://doi.org/10.3928/1081-597X-19931101-17","url":null,"abstract":"","PeriodicalId":77346,"journal":{"name":"Refractive & corneal surgery","volume":"9 6 1","pages":"488"},"PeriodicalIF":0.0,"publicationDate":"1993-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70144901","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"European Society of Cataract and Refractive Surgeons. 11th annual conference. August 29-September 2, 1993 Innsbruck, Austria.","authors":"G O Waring","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":77346,"journal":{"name":"Refractive & corneal surgery","volume":"9 6","pages":"486-7"},"PeriodicalIF":0.0,"publicationDate":"1993-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"19110173","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Intrastromal corneal ring--one-year results of first implants in humans: a preliminary nonfunctional eye study.","authors":"W. Nosé, R. Neves, D. Schanzlin, Rubens Belfort","doi":"10.3928/1081-597X-19931101-09","DOIUrl":"https://doi.org/10.3928/1081-597X-19931101-09","url":null,"abstract":"BACKGROUND\u0000The Intrastromal Corneal Ring (ICR) is a new investigational medical device designed to alter corneal curvature without surgical intervention in the central cornea. The ring is inserted between the layers of the stroma in the cornea's periphery at two-thirds depth through an approximately 2-millimeter incision.\u0000\u0000\u0000METHODS\u0000To investigate the safety and refractive effect of implanting an ICR of a given thickness (0.30 mm) and outer diameter (7.70 mm) into human corneas, an ICR was implanted into one nonfunctional eye of each of three patients during the period of March to May, 1991. One predesignated ICR was successfully explanted 5 months after implantation to evaluate the feasibility of ICR removal and to observe the effect of ring removal on corneal curvature. Patients were followed for 1 year after the initial implant procedure.\u0000\u0000\u0000RESULTS\u0000The three implant procedures and postoperative courses proceeded without any significant complications. Approximately 2.00 D of central corneal flattening was achieved in all eyes. No adverse reactions or other medically-significant complications were observed over a 1-year follow-up period. The patient who underwent ICR removal experienced no perioperative complications, and the patient's cornea has remained stable with a return to its preoperative curvature.\u0000\u0000\u0000CONCLUSION\u0000Although this study is preliminary and limited in scope, we have demonstrated that the ICR can be tolerated safely in the human cornea and results in a flattening of the corneal curvature that is stable for up to a year after insertion. The successful removal of the ICR begins to establish reversibility of the procedure and induced refractive effect.","PeriodicalId":77346,"journal":{"name":"Refractive & corneal surgery","volume":"9 6 1","pages":"452-8"},"PeriodicalIF":0.0,"publicationDate":"1993-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70144720","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}